Fluorotechnics Q2 Revenues Drop to $129K | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluorotechnics last week reported that second-quarter revenues from customers had dropped to A$119,189 ($129,151), down from A$1.9 million ($2.1 million) a year ago.

For the quarter ended June 30, R&D expenses were sliced to A$9,425 from $264,231 a yaer ago, while SG&A spending dropped to A$1,169 from A$354,777.

Net operating cash flows came in at a loss of A$87,601, down from a loss of A$1.6 million in the second quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.